1 - 7 of 7 articles
This January, when New York Gov. Andrew Cuomo recommended substituting cannabis for methadone and buprenorphine by saying opioid use disorder (OUD) would be a listed indication for its medical use in the state, he aroused the ire of treatment professionals across the state — and country (see...
Results of a study published this month in Psychiatric Services suggest that if states want to ensure greater provision of evidence‐based care for opioid use disorder (OUD), expanding Medicaid offers an effective strategy for doing so. At the same time, the study data indicate that Medicaid...
Reckitt Benckiser (RB) Group, previously Reckitt Benckiser Pharmaceuticals, former owner of Indivior, and maker of Suboxone, has agreed to pay the U.S. government $1.4 billion in exchange for not being prosecuted for marketing of the medication. In 2014, Reckitt Benckiser spun off Indivior, and...
Seven opioid treatment programs (OTPs) at 12 locations in New York state will participate in a study that uses telemedicine to integrate the treatment of opioid use disorder (OUD) and hepatitis C virus (HCV). The goal is to achieve better outcomes by delivering HCV treatment on‐site via...
The National Conference on Addiction Disorders will be held Aug. 15–18 in Baltimore. For more information, go to https://east.theaddictionconference.com/.
At first, we wondered why the shooting and two deaths last week at Man Alive, the first opioid treatment program (OTP) in the country, did not get more news coverage. Then, we decided maybe that was a good thing. OTPs have a hard enough time siting their programs without adding “possible...
Last week, the federal Centers for Disease Control and Prevention (CDC) released “provisional counts” showing a decline of 5.1% in overdose deaths from 2017 to 2018. The data, from the CDC's National Center for Health Statistics, prompted a July 17 statement — the same day it was released — from...
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.